Figure 2

Evaluation of systemic oxidative stress. 8-OHdG, 8-hydroxy-2′-deoxyguanosine; DM, diabetes mellitus; CKD, chronic kidney disease; INS, insulin; APO, apocynin. ^aversus Control group, P < 0.05, ^bversus DM group, P < 0.05, ^cversus CKD group, P < 0.05, ^dversus CKD + DM, P < 0.05.